Stratification of postremission therapy in patients with acute myeloid leukemia <= 60 years according to the karyotype: Results of the German multicenter treatment trials AML HD93 and AML HD98-A

Schlenk, RF Frohling, S Del Valle, F Hartmann, F Glasmacher, A Fischer, JT Grimminger, W Weber, C Weber, W Gunzer, U Gotze, K Waterhouse, C Benner, A Dohner, K Haas, R Ho, AD Dohner, H

Rf. Schlenk et al., Stratification of postremission therapy in patients with acute myeloid leukemia <= 60 years according to the karyotype: Results of the German multicenter treatment trials AML HD93 and AML HD98-A, HEMAT BLOOD, 40, 2001, pp. 470-476

Current Book Contents

ACUTE LEUKEMIAS VIII: PROGNOSTIC FACTORS AND TREATMENT STRATEGIES → ACNP

40

2001

470 - 476

ISI